These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22745589)

  • 1. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.
    Jung Y; Shiozawa Y; Wang J; McGregor N; Dai J; Park SI; Berry JE; Havens AM; Joseph J; Kim JK; Patel L; Carmeliet P; Daignault S; Keller ET; McCauley LK; Pienta KJ; Taichman RS
    Neoplasia; 2012 May; 14(5):429-39. PubMed ID: 22745589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
    Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
    Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
    Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
    J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.
    Taichman RS; Patel LR; Bedenis R; Wang J; Weidner S; Schumann T; Yumoto K; Berry JE; Shiozawa Y; Pienta KJ
    PLoS One; 2013; 8(4):e61873. PubMed ID: 23637920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
    Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
    Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
    Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
    Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow.
    Wang C; Wang J; Chen K; Pang H; Li X; Zhu J; Ma Y; Qiu T; Li W; Xie J; Zhang J
    Cancer Sci; 2020 Oct; 111(10):3600-3612. PubMed ID: 32770813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
    Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS
    Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
    Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
    Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
    Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical Changes in the Niche Following Tumor Cell Invasion.
    Decker AM; Cackowski FC; Jung Y; Taichman RS
    J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
    Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
    Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
    Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
    J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
    Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
    Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
    Li X; Liao J; Park SI; Koh AJ; Sadler WD; Pienta KJ; Rosol TJ; McCauley LK
    Bone; 2011 Jun; 48(6):1354-61. PubMed ID: 21419883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of Prostate Cancer Bone Metastasis.
    Park SH; Eber MR; Shiozawa Y
    Methods Mol Biol; 2019; 1914():295-308. PubMed ID: 30729472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
    Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
    Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.